Silver Spring, Maryland–(ENEWSPF)–January 8, 2014. The U.S. Food and Drug Administration today approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
FDA Approves Farxiga to Treat Type 2 Diabetes
More in Health and Fitness:
